AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 39347763 — intervention group
Group type: EXPERIMENTAL
Intervention: Home tobacco environment
Number of subjects: 0
Study 39347788 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Minds Program (self-guided meditation app)
Number of subjects: 0
Study 39347788 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 0
Study 39347889 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with PAD (148 patients)
Number of subjects: 713
Study 39347889 — intervention group
Group type: COMPARATOR
Intervention: Patients without PAD (565 patients)
Number of subjects: 713
Study 39347926 — intervention group
Group type: EXPERIMENTAL
Intervention: Ixekizumab Q4W
Number of subjects: 438
Study 39347926 — intervention group
Group type: EXPERIMENTAL
Intervention: Ixekizumab Q2W
Number of subjects: 438
Study 39347926 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 438
Study 39348147 — intervention group
Group type: EXPERIMENTAL
Intervention: HPSA + FIT
Number of subjects: 240000
Study 39348147 — intervention group
Group type: COMPARATOR
Intervention: FIT alone
Number of subjects: 240000
Study 39348299 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine
Number of subjects: 0
Study 39348302 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative Care to Alleviate Symptoms and Adjust to Illness
Number of subjects: 101
Study 39348302 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 101
Study 39348366 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemp-derived cannabidiol
Number of subjects: 0
Study 39348366 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 39348419 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous hematopoietic stem cell transplant (HSCT)
Number of subjects: 0
Study 39348419 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapies for dcSSc
Number of subjects: 0
Study 39348472 — intervention group
Group type: EXPERIMENTAL
Intervention: Trebananib (30 mg/kg weekly) plus Pembrolizumab (200 mg every 3 weeks)
Number of subjects: 0
Study 39348664 — intervention group
Group type: EXPERIMENTAL
Intervention: R-CHOP therapy (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone)
Number of subjects: 51
Study 39348664 — intervention group
Group type: EXPERIMENTAL
Intervention: R-CHOP therapy
Number of subjects: 51
Study 39348677 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrive with Me (TWM) intervention
Number of subjects: 401
Study 39348677 — intervention group
Group type: COMPARATOR
Intervention: Weekly email newsletter (control)
Number of subjects: 401
Study 39348690 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized 8- to 10-hour time-restricted eating (TRE) intervention for 3 months
Number of subjects: 108
Study 39348690 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care (SOC) nutritional counseling alone
Number of subjects: 108
Study 39348695 — intervention group
Group type: EXPERIMENTAL
Intervention: Suicide Care (SC)
Number of subjects: 255789
Study 39348695 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 255789
Study 39348705 — intervention group
Group type: EXPERIMENTAL
Intervention: <10 g/dL transfusion strategy
Number of subjects: 3492
Study 39348705 — intervention group
Group type: EXPERIMENTAL
Intervention: <9 g/dL transfusion strategy
Number of subjects: 3492
Study 39348705 — intervention group
Group type: EXPERIMENTAL
Intervention: <8 g/dL transfusion strategy
Number of subjects: 3492
Study 39348705 — intervention group
Group type: EXPERIMENTAL
Intervention: <7 g/dL transfusion strategy
Number of subjects: 3492
Study 39348893 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-Guided Web-Based Intervention (SGWI)
Number of subjects: 36
Study 39348893 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-Guided Web-Based Intervention with Chat Support (SGWI+C)
Number of subjects: 36
Study 39349050 — intervention group
Group type: EXPERIMENTAL
Intervention: Dobutamine stress echocardiography (DSE)
Number of subjects: 102
Study 39349061 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant ipilimumab plus nivolumab with chemoradiotherapy (IPI-NIVO-CRT); IPI 1 mg/kg intravenous and NIVO 360 mg intravenous on day-1, followed by chemotherapy plus NIVO 360 mg 3 weeks later; Thoracic radiotherapy was 50 or 60 Gy, in once-daily doses of 2 Gy.
Number of subjects: 30
Study 39349152 — intervention group
Group type: EXPERIMENTAL
Intervention: Goldspire™ platform (personalized immunotherapy combining whole tumor-derived cells with antisense oligonucleotide IMV-001 against IGF-1R)
Number of subjects: 0
Study 39349152 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination treatment with Goldspire™ and anti-PD-1
Number of subjects: 0
Study 39349152 — intervention group
Group type: EXPERIMENTAL
Intervention: Goldspire™ platform
Number of subjects: 0
Study 39349158 — intervention group
Group type: EXPERIMENTAL
Intervention: Kansas City Cardiomyopathy Questionnaire (KCCQ-23) Overall Summary Scores (OSS)
Number of subjects: 0
Study 39349158 — intervention group
Group type: EXPERIMENTAL
Intervention: Kansas City Cardiomyopathy Questionnaire (KCCQ-23) Clinical Summary Scores (CSS)
Number of subjects: 0
Study 39349158 — intervention group
Group type: EXPERIMENTAL
Intervention: Kansas City Cardiomyopathy Questionnaire (KCCQ-23) OSS and CSS
Number of subjects: 0
Study 39349158 — intervention group
Group type: EXPERIMENTAL
Intervention: Kansas City Cardiomyopathy Questionnaire (KCCQ-23) scores
Number of subjects: 0
Study 39349282 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI) in NSTEMI patients
Number of subjects: 2806
Study 39349282 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI) in STEMI patients
Number of subjects: 2806
Study 39349282 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimal secondary prevention therapy at discharge
Number of subjects: 2806
Study 39349282 — intervention group
Group type: EXPERIMENTAL
Intervention: In-hospital major bleeding
Number of subjects: 2806
Study 39349282 — intervention group
Group type: EXPERIMENTAL
Intervention: In-hospital death
Number of subjects: 2806
Study 39349374 — intervention group
Group type: EXPERIMENTAL
Intervention: PowerPICC catheter
Number of subjects: 451
Study 39349375 — intervention group
Group type: EXPERIMENTAL
Intervention: Cook's balloon for labour induction
Number of subjects: 0
Study 39349375 — intervention group
Group type: COMPARATOR
Intervention: Dinoprostone for labour induction
Number of subjects: 0
Study 39349477 — intervention group
Group type: EXPERIMENTAL
Intervention: Ribociclib
Number of subjects: 14
Study 39349554 — intervention group
Group type: EXPERIMENTAL
Intervention: E2 cypionate (5 mg, IM) and micronized P4 (200 mg, PO)
Number of subjects: 10
Study 39349554 — intervention group
Group type: COMPARATOR
Intervention: Placebo-equivalent
Number of subjects: 10
Study 39349619 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital information about genetic testing
Number of subjects: 1140
Study 39349619 — intervention group
Group type: COMPARATOR
Intervention: Pre-test genetic counselling consultation
Number of subjects: 1140
Study 39350021 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral glucose intake during OGTT
Number of subjects: 14
Study 39350097 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided internet-based self-help programme (Spring)
Number of subjects: 50
Study 39350097 — intervention group
Group type: COMPARATOR
Intervention: Delayed treatment control group (access to the programme five months after randomization)
Number of subjects: 50
Study 39350097 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided trauma-focused ICBT intervention (both groups)
Number of subjects: 50
Study 39350107 — intervention group
Group type: EXPERIMENTAL
Intervention: Implants in lateral incisor positions
Number of subjects: 50
Study 39350107 — intervention group
Group type: COMPARATOR
Intervention: Implants in canine positions
Number of subjects: 50
Study 39350120 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-led intervention (6 weeks of peer-led sessions supervised by nurses)
Number of subjects: 70
Study 39350120 — intervention group
Group type: COMPARATOR
Intervention: mHealth application for emotional wellness based on CBT (6 weeks)
Number of subjects: 70
Study 39350133 — intervention group
Group type: EXPERIMENTAL
Intervention: O-HTN Bundle implementation in outpatient clinics
Number of subjects: 20
Study 39350133 — intervention group
Group type: EXPERIMENTAL
Intervention: O-HTN Bundle implementation
Number of subjects: 20
Study 39350137 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-management program (SEMPO) delivered 3-4 months after injury
Number of subjects: 220
Study 39350137 — intervention group
Group type: COMPARATOR
Intervention: Control group (details not specified)
Number of subjects: 220
Study 39350137 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-management program (SEMPO)
Number of subjects: 220
Study 39350145 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge Insight Tools (KIT)
Number of subjects: 60
Study 39350156 — intervention group
Group type: EXPERIMENTAL
Intervention: EyeSi simulator training (four two-hour sessions)
Number of subjects: 16
Study 39350186 — intervention group
Group type: EXPERIMENTAL
Intervention: LSTM-based machine-learning algorithm
Number of subjects: 80
Study 39350186 — intervention group
Group type: EXPERIMENTAL
Intervention: JOA scores analyzed at 1, 3, 6, and 12 months postoperative
Number of subjects: 80
Study 39350186 — intervention group
Group type: EXPERIMENTAL
Intervention: PASS defined as JOA score ≥ 14.25 at 24 months
Number of subjects: 80
Study 39350195 — intervention group
Group type: EXPERIMENTAL
Intervention: CCTA-guided strategy
Number of subjects: 3400
Study 39350195 — intervention group
Group type: COMPARATOR
Intervention: Traditional cardiovascular risk score-guided strategy (usual care group)
Number of subjects: 3400
Study 39350201 — intervention group
Group type: EXPERIMENTAL
Intervention: High-UPF Mediterranean diet (3-month intervention)
Number of subjects: 50
Study 39350201 — intervention group
Group type: COMPARATOR
Intervention: Low-UPF Mediterranean diet (3-month control)
Number of subjects: 50
Study 39350201 — intervention group
Group type: EXPERIMENTAL
Intervention: High-UPF Mediterranean diet
Number of subjects: 50
Study 39350201 — intervention group
Group type: COMPARATOR
Intervention: Low-UPF Mediterranean diet
Number of subjects: 50
Study 39350232 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% albumin
Number of subjects: 0
Study 39350232 — intervention group
Group type: COMPARATOR
Intervention: Ringer's Lactate (RL)
Number of subjects: 0
Study 39350270 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual MSC + MC
Number of subjects: 97
Study 39350270 — intervention group
Group type: EXPERIMENTAL
Intervention: MC-Only
Number of subjects: 97
Study 39350270 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 97
Study 39350291 — intervention group
Group type: EXPERIMENTAL
Intervention: Online home-based group
Number of subjects: 44
Study 39350291 — intervention group
Group type: EXPERIMENTAL
Intervention: Gym-based group
Number of subjects: 44
Study 39350291 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall experience of participants
Number of subjects: 44
Study 39350291 — intervention group
Group type: EXPERIMENTAL
Intervention: Eligibility and recruitment rates
Number of subjects: 44
Study 39350291 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up
Number of subjects: 44
Study 39350292 — intervention group
Group type: EXPERIMENTAL
Intervention: Alberta Family Integrated Care
Number of subjects: 0
Study 39350292 — intervention group
Group type: EXPERIMENTAL
Intervention: Strategic inflection points identified
Number of subjects: 0
Study 39350322 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial body temperature (BT) >36.8°C in NSTE-ACS patients
Number of subjects: 1044
Study 39350322 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial body temperature (BT) in STEMI patients
Number of subjects: 1044
Study 39350322 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial body temperature (BT) in NSTE-ACS patients
Number of subjects: 1044
Study 39350322 — intervention group
Group type: EXPERIMENTAL
Intervention: High-sensitivity C-reactive protein (hs-CRP)
Number of subjects: 1044
Study 39350350 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood flow restriction training (BFRT)
Number of subjects: 48
Study 39350350 — intervention group
Group type: COMPARATOR
Intervention: Standard of care strength training with a sham unit
Number of subjects: 48
Study 39350441 — intervention group
Group type: EXPERIMENTAL
Intervention: MyDiaMate intervention for 6 months
Number of subjects: 660
Study 39350441 — intervention group
Group type: COMPARATOR
Intervention: Care as usual for 3 months (access after 3 months)
Number of subjects: 660
Study 39350528 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamified app intervention
Number of subjects: 101
Study 39350528 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 101
Study 39350940 — intervention group
Group type: EXPERIMENTAL
Intervention: Augmented soundscape intervention delivered in their room in the morning and evening
Number of subjects: 0
Study 39350940 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 0
Study 39350954 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjunctive minocycline
Number of subjects: 240
Study 39350954 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjunctive celecoxib
Number of subjects: 240
Study 39350954 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 240
Study 39351080 — intervention group
Group type: EXPERIMENTAL
Intervention: COACH intervention with mouthpiece-based head kinematic sensors
Number of subjects: 0
Study 39351080 — intervention group
Group type: COMPARATOR
Intervention: Control teams fitted with mouthpiece-based head kinematic sensors
Number of subjects: 0
Study 39351312 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative exercise intervention (4-week program including aerobic exercise three times a week, muscle strengthening exercise twice a week, and respiratory muscle exercise once a day)
Number of subjects: 0
Study 39351353 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised exercise intervention (SUP) - 16-week periodized aerobic and resistance exercise program, performed three days per week, supervised through video conference technology.
Number of subjects: 45
Study 39351353 — intervention group
Group type: EXPERIMENTAL
Intervention: Unsupervised exercise (UNSUP) - 16-week, telehealth-based, periodized aerobic and resistance exercise program, performed three days per week, using the same exercise prescription parameters as the SUP group.
Number of subjects: 45
Study 39351353 — intervention group
Group type: COMPARATOR
Intervention: Attention control (AC) - 16-week home-based stretching program.
Number of subjects: 45
Study 39351353 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (SUP, UNSUP, AC)
Number of subjects: 45
Study 39351662 — intervention group
Group type: EXPERIMENTAL
Intervention: IV thrombolysis (IVT)
Number of subjects: 68
Study 39351662 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical thrombectomy
Number of subjects: 68
Study 39351662 — intervention group
Group type: EXPERIMENTAL
Intervention: IVT + mechanical thrombectomy
Number of subjects: 68
Study 39351676 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrathin-strut biodegradable-polymer sirolimus-eluting Supraflex Cruz stent
Number of subjects: 741
Study 39351676 — intervention group
Group type: COMPARATOR
Intervention: Thin-strut biodegradable-polymer sirolimus-eluting Ultimaster Tansei stent
Number of subjects: 741
Study 39351703 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided bone regeneration (GBR) using deproteinized bovine bone mineral (DBBM), autologous bone, and a resorbable collagen membrane
Number of subjects: 45
Study 39351849 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with severe hypertension and severe hypertensive retinopathy
Number of subjects: 302
Study 39351849 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with severe retinopathy
Number of subjects: 302
Study 39351849 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients treated without the use of IV therapy
Number of subjects: 302
Study 39351849 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with normal or low renin level
Number of subjects: 302
Study 39351849 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients not on antihypertensive therapy at enrollment
Number of subjects: 302
Study 39351881 — intervention group
Group type: COMPARATOR
Intervention: Moderate-dose vitamin D (3200 IU/day)
Number of subjects: 314
Study 39351881 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose vitamin D (5000 IU/day to 7943 IU/day)
Number of subjects: 314
Study 39351881 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 314
Study 39351881 — intervention group
Group type: COMPARATOR
Intervention: Moderate-dose vitamin D (800 IU/day to 2000 IU/day)
Number of subjects: 314
Study 39351902 — intervention group
Group type: EXPERIMENTAL
Intervention: C-CAR066, an autologous fully human anti-CD20 CAR-T therapy, administered as a single intravenous infusion at a target dose of 2.0 × 10^6 CAR-T cells per kg.
Number of subjects: 0
Study 39351987 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic intervention
Number of subjects: 81
Study 39351987 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 81
Study 39351987 — intervention group
Group type: EXPERIMENTAL
Intervention: Demographic characteristics (age, education, income, partnership status, ethnicity)
Number of subjects: 81
Study 39351987 — intervention group
Group type: EXPERIMENTAL
Intervention: Demographic characteristics (Black vs. White participants)
Number of subjects: 81
Study 39351987 — intervention group
Group type: EXPERIMENTAL
Intervention: Demographic characteristics (marital status)
Number of subjects: 81
Study 39352135 — intervention group
Group type: EXPERIMENTAL
Intervention: SPR720, phosphate ester prodrug, oral administration, dosage and duration not specified
Number of subjects: 0
Study 39352173 — intervention group
Group type: EXPERIMENTAL
Intervention: Coping Long Term with Active Suicide Program (CLASP) post-discharge clinical outreach intervention
Number of subjects: 850
Study 39352173 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 850
Study 39352252 — intervention group
Group type: EXPERIMENTAL
Intervention: AG1® supplementation
Number of subjects: 0
Study 39352252 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 39352296 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended partial pulpotomy (E-PP)
Number of subjects: 81
Study 39352296 — intervention group
Group type: EXPERIMENTAL
Intervention: Restricted partial pulpotomy (R-PP)
Number of subjects: 81
Study 39352309 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylation at eight CpG sites within TERT intron 2
Number of subjects: 190
Study 39352309 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypermethylation at chr5:1289663
Number of subjects: 190
Study 39352309 — intervention group
Group type: COMPARATOR
Intervention: Rare alleles of rs27070 and rs459961 in normal or dysplastic cervical tissues
Number of subjects: 190
Study 39352309 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV infection
Number of subjects: 190
Study 39352340 — intervention group
Group type: EXPERIMENTAL
Intervention: Finerenone
Number of subjects: 6001
Study 39352340 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6001
Study 39352339 — intervention group
Group type: EXPERIMENTAL
Intervention: Aficamten
Number of subjects: 282
Study 39352339 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 282
Study 39352476 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 g nori (aiming to provide 2.4 µg vitamin B)
Number of subjects: 30
Study 39352476 — intervention group
Group type: COMPARATOR
Intervention: Control (no nori)
Number of subjects: 30
Study 39352661 — intervention group
Group type: EXPERIMENTAL
Intervention: COVID-19 patients
Number of subjects: 118
Study 39352661 — intervention group
Group type: COMPARATOR
Intervention: SARS-CoV-2 negative controls
Number of subjects: 118
Study 39352661 — intervention group
Group type: EXPERIMENTAL
Intervention: COVID-19 patients with delirium
Number of subjects: 118
Study 39352661 — intervention group
Group type: EXPERIMENTAL
Intervention: Body-fluid biomarkers
Number of subjects: 118
Study 39352692 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-acquired infections
Number of subjects: 1000
Study 39352692 — intervention group
Group type: EXPERIMENTAL
Intervention: Confirmed microbiological diagnosis
Number of subjects: 1000
Study 39352692 — intervention group
Group type: EXPERIMENTAL
Intervention: Viral cause of sepsis
Number of subjects: 1000
Study 39352692 — intervention group
Group type: EXPERIMENTAL
Intervention: Leptospirosis
Number of subjects: 1000
Study 39352692 — intervention group
Group type: EXPERIMENTAL
Intervention: Scrub typhus
Number of subjects: 1000
Study 39352692 — intervention group
Group type: EXPERIMENTAL
Intervention: Dengue
Number of subjects: 1000
Study 39352692 — intervention group
Group type: EXPERIMENTAL
Intervention: Kyasanur forest disease
Number of subjects: 1000
Study 39352692 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance to 3rd generation cephalosporins and carbapenems
Number of subjects: 1000
Study 39352693 — intervention group
Group type: EXPERIMENTAL
Intervention: TEACHH intervention (health literacy-informed teaching, pictorial materials, color- and shape-coded medication labels, medication demonstration, two Zoom-based follow-up visits)
Number of subjects: 26
Study 39352693 — intervention group
Group type: EXPERIMENTAL
Intervention: TEACHH intervention
Number of subjects: 26
Study 39352693 — intervention group
Group type: COMPARATOR
Intervention: Standardized care (SC)
Number of subjects: 26
Study 39352732 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital health tools (DH)
Number of subjects: 44
Study 39352737 — intervention group
Group type: EXPERIMENTAL
Intervention: MyREADY Transition HIT platform
Number of subjects: 0
Study 39352737 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 39352751 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose IV ascorbic acid therapy
Number of subjects: 10
Study 39352759 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 39352775 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.2% via intercostal catheter at a flow rate of 6-8 ml/h for 72 hours after surgery
Number of subjects: 32
Study 39352775 — intervention group
Group type: COMPARATOR
Intervention: Placebo via intercostal catheter
Number of subjects: 32